We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
COMEAP summary of the science linking long-term air pollution exposure with SARS-CoV-2 infection and adverse COVID-19 outcomes.
Modelled proportion of the population (prevalence) currently infected with SARS-CoV-2 (COVID-19) and other key epidemiological metrics as the study progresses. This data is collected from citizens in England and Scotland and will include regional and age breakdowns. The study has...
Paper prepared by academics at New York University (NYU) on COVID-19 and hospitalisation.
Clinical guidance on myocarditis and pericarditis after COVID-19 vaccination for healthcare professionals.
This trial explored whether manipulating the source of public health information would shift attitudes, knowledge and behaviour.
Consensus statement from the Scientific Pandemic Influenza Group on Modelling, Operational sub-group (SPI-M-O) for the Scientific Advisory Group for Emergencies (SAGE).
Weekly HM Prison and Probation Service (HMPPS) COVID-19 data.
Paper prepared by the Scientific Pandemic Influenza Group on Modelling, Operational sub-group (SPI-M-O).
Estimates for England, Wales, Northern Ireland and Scotland. This survey is being delivered in partnership with the University of Oxford, University of Manchester, UK Health Security Agency and Wellcome Trust. This study is jointly led by the ONS and the Department for Health and...
Information for healthcare professionals on the clinical investigation and management of COVID-19 vaccine induced thrombosis and thrombocytopenia (VITT).
Find out about the changes if you are exporting personal protective equipment (PPE) during the coronavirus pandemic.
Current Dilemmas Facing Longitudinal Research in Low- and Middle-Income Countries
The WICH tool presents a number of metrics across a broad range of themes, such as social determinants of health, behavioural risk factors and mortality, to enable users to assess the indirect impacts of COVID-19 on health. Where possible data...
The government has pledged £750 million to ensure VCSE can continue their vital work supporting the country during the coronavirus (COVID-19) outbreak, including £200 million for the Coronavirus Community Support Fund, along with an additional £150 million from dormant bank...
Modelled proportion of the population (prevalence) in England and Scotland currently infected with SARS-CoV-2 (COVID-19), incidence of new infections, the infection hospitalisation rate (IHR) and the infection fatality risk (IFR). Joint study with the Office for National Statistics.
The DHSC-led COVID-19 Antivirals and Therapeutics Taskforce co-ordinates the end-to-end provision of treatments for coronavirus (COVID-19) in the UK so that patients get access to safe and effective treatments as soon as possible.
Paper prepared by the Scientific Pandemic Influenza Group on Behaviours (SPI-B).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).